PT3010488T - Lípidos estereoespecíficos para a terapia locorregional com sistemas nanotransportadores sensíveis a estímulos de circulação a longo prazo - Google Patents
Lípidos estereoespecíficos para a terapia locorregional com sistemas nanotransportadores sensíveis a estímulos de circulação a longo prazoInfo
- Publication number
- PT3010488T PT3010488T PT147309322T PT14730932T PT3010488T PT 3010488 T PT3010488 T PT 3010488T PT 147309322 T PT147309322 T PT 147309322T PT 14730932 T PT14730932 T PT 14730932T PT 3010488 T PT3010488 T PT 3010488T
- Authority
- PT
- Portugal
- Prior art keywords
- stimuli
- long
- sensitive nanocarrier
- term circulating
- nanocarrier systems
- Prior art date
Links
- 150000002632 lipids Chemical class 0.000 title 1
- 230000007774 longterm Effects 0.000 title 1
- 239000002539 nanocarrier Substances 0.000 title 1
- 230000000707 stereoselective effect Effects 0.000 title 1
- 238000002560 therapeutic procedure Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
- C07F9/10—Phosphatides, e.g. lecithin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
- C07F9/10—Phosphatides, e.g. lecithin
- C07F9/106—Adducts, complexes, salts of phosphatides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Dispersion Chemistry (AREA)
- Dermatology (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Biophysics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Communicable Diseases (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Psychiatry (AREA)
- Physical Education & Sports Medicine (AREA)
- Urology & Nephrology (AREA)
- Oncology (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Diabetes (AREA)
- Hematology (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP13172469 | 2013-06-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
PT3010488T true PT3010488T (pt) | 2021-08-03 |
Family
ID=48628349
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT147309322T PT3010488T (pt) | 2013-06-18 | 2014-06-18 | Lípidos estereoespecíficos para a terapia locorregional com sistemas nanotransportadores sensíveis a estímulos de circulação a longo prazo |
Country Status (18)
Country | Link |
---|---|
US (1) | US10251838B2 (pt) |
EP (1) | EP3010488B1 (pt) |
JP (1) | JP6501765B2 (pt) |
KR (1) | KR102242183B1 (pt) |
CN (1) | CN105431139B (pt) |
AU (1) | AU2014283264C1 (pt) |
BR (1) | BR112015031495B1 (pt) |
CA (1) | CA2922627C (pt) |
DK (1) | DK3010488T3 (pt) |
EA (1) | EA033891B1 (pt) |
ES (1) | ES2881699T3 (pt) |
HK (1) | HK1217647A1 (pt) |
HU (1) | HUE054713T2 (pt) |
IL (1) | IL243212B (pt) |
MX (1) | MX2015017505A (pt) |
PL (1) | PL3010488T3 (pt) |
PT (1) | PT3010488T (pt) |
WO (1) | WO2014202680A1 (pt) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2018510859A (ja) * | 2015-03-17 | 2018-04-19 | レオン−ナノドラッグズ ゲーエムベーハー | 安定化されたボロン酸化合物を含むナノ粒子 |
CN116033906A (zh) | 2020-07-07 | 2023-04-28 | 特默佐梅有限公司 | 脂质体制剂 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FI874742A (fi) * | 1987-10-28 | 1989-04-29 | K & V Licencing Oy | Foerfarande foer framstaellning av liposomer. |
ES2202576T3 (es) * | 1996-02-16 | 2004-04-01 | Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. | Fosfatidil-oligogliceroles. |
US6177282B1 (en) * | 1997-08-12 | 2001-01-23 | Mcintyre John A. | Antigens embedded in thermoplastic |
US6200598B1 (en) | 1998-06-18 | 2001-03-13 | Duke University | Temperature-sensitive liposomal formulation |
DE10107165A1 (de) * | 2001-02-15 | 2002-08-29 | Max Planck Gesellschaft | Thermolabiles Liposom mit geregelter Freigabetemperatur |
DE10242367A1 (de) | 2002-09-12 | 2004-03-18 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. | Thermolabiles Liposom mit geregelter Freigabetemperatur |
KR20100092016A (ko) * | 2007-11-30 | 2010-08-19 | 엔도 파마슈티컬즈, 솔루션스 아이엔씨. | 방광암 치료용 발루비신을 갖는 방광내 투약 조성물 |
JP5382567B2 (ja) | 2008-05-02 | 2014-01-08 | 公立大学法人大阪府立大学 | 温度感受性リポソーム |
EP2638896A1 (en) * | 2012-03-14 | 2013-09-18 | Bioneer A/S | Cationic liposomal drug delivery system for specific targeting of human cd14+ monocytes in whole blood |
-
2014
- 2014-06-18 EA EA201690029A patent/EA033891B1/ru not_active IP Right Cessation
- 2014-06-18 AU AU2014283264A patent/AU2014283264C1/en active Active
- 2014-06-18 KR KR1020167000760A patent/KR102242183B1/ko active IP Right Grant
- 2014-06-18 ES ES14730932T patent/ES2881699T3/es active Active
- 2014-06-18 US US14/899,174 patent/US10251838B2/en active Active
- 2014-06-18 MX MX2015017505A patent/MX2015017505A/es active IP Right Grant
- 2014-06-18 BR BR112015031495-3A patent/BR112015031495B1/pt active IP Right Grant
- 2014-06-18 DK DK14730932.2T patent/DK3010488T3/da active
- 2014-06-18 HU HUE14730932A patent/HUE054713T2/hu unknown
- 2014-06-18 CN CN201480042361.0A patent/CN105431139B/zh active Active
- 2014-06-18 CA CA2922627A patent/CA2922627C/en active Active
- 2014-06-18 JP JP2016520468A patent/JP6501765B2/ja active Active
- 2014-06-18 PT PT147309322T patent/PT3010488T/pt unknown
- 2014-06-18 EP EP14730932.2A patent/EP3010488B1/de active Active
- 2014-06-18 PL PL14730932T patent/PL3010488T3/pl unknown
- 2014-06-18 WO PCT/EP2014/062849 patent/WO2014202680A1/de active Application Filing
-
2015
- 2015-12-17 IL IL243212A patent/IL243212B/en active IP Right Grant
-
2016
- 2016-05-17 HK HK16105658.4A patent/HK1217647A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
EP3010488A1 (de) | 2016-04-27 |
JP2016523242A (ja) | 2016-08-08 |
IL243212B (en) | 2020-01-30 |
ES2881699T3 (es) | 2021-11-30 |
CN105431139A (zh) | 2016-03-23 |
CA2922627A1 (en) | 2014-12-24 |
CN105431139B (zh) | 2019-10-01 |
DK3010488T3 (da) | 2021-05-31 |
IL243212A0 (en) | 2016-02-29 |
AU2014283264B2 (en) | 2019-05-02 |
CA2922627C (en) | 2022-03-08 |
BR112015031495A2 (pt) | 2017-07-25 |
EP3010488B1 (de) | 2021-05-05 |
EA201690029A1 (ru) | 2016-05-31 |
BR112015031495B1 (pt) | 2023-04-11 |
AU2014283264C1 (en) | 2019-08-29 |
JP6501765B2 (ja) | 2019-04-17 |
US10251838B2 (en) | 2019-04-09 |
HUE054713T2 (hu) | 2021-09-28 |
US20160136092A1 (en) | 2016-05-19 |
EA033891B1 (ru) | 2019-12-05 |
KR20160026984A (ko) | 2016-03-09 |
HK1217647A1 (zh) | 2017-01-20 |
KR102242183B1 (ko) | 2021-04-20 |
PL3010488T3 (pl) | 2021-11-15 |
WO2014202680A1 (de) | 2014-12-24 |
MX2015017505A (es) | 2016-08-05 |
AU2014283264A1 (en) | 2016-02-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL279408B (en) | An infusion system to prevent the wrong referral of a large number of drugs | |
EP2968043A4 (en) | Patient repositioning system | |
ZA201507315B (en) | Selective gene therapy expression system | |
EP2968749A4 (en) | DOUBLE ACTION PERFUSION SYSTEM | |
GB2513596B (en) | Image-guided radiotherapy | |
SG11201605156WA (en) | Ct systems and methods | |
GB201605242D0 (en) | Catheter | |
ZA201507755B (en) | Tumor-selective combination therapy | |
GB201321078D0 (en) | Syringe assemblies | |
EP2987531A4 (en) | PARTICULATE THERAPY SYSTEM | |
GB201310755D0 (en) | Therapy | |
HK1215152A1 (zh) | 具有受控柔性的輸送導管 | |
IL245618A0 (en) | Inhalation medicine | |
TWI562796B (en) | Catheter system | |
HK1222139A1 (zh) | 可拆開導管 | |
IL243212B (en) | Stereospecific lipids for local treatment with a touch-sensitive and long-lasting nano-carrier system | |
HK1211243A1 (en) | An inhalable medicament | |
IL233698B (en) | A catheter of multiple shapes | |
GB201313356D0 (en) | Therapeutic Intervention | |
GB201518731D0 (en) | Tumour Therapy | |
EP2951661A4 (en) | CONTROLLED HEAT DELIVERY | |
GB201308365D0 (en) | Tumour therapy | |
GB201316687D0 (en) | Computer controlled inhaler system | |
GB201320786D0 (en) | Medicament | |
GB201304807D0 (en) | Catheter |